Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis. | Hepatology | 2022 | 34626132 | PubTator, text mining | PubMed |
| BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial. | Hepatology | 2022 | 34605045 | PubTator, text mining | PubMed |
| Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity. | Hepatol Commun | 2022 | 34558849 | PubTator, text mining | PubMed |
| Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma. | Int Forum Allergy Rhinol | 2022 | 34510780 | PubTator, text mining | PubMed |
| In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types. | Clin Transl Oncol | 2022 | 34370182 | PubTator, text mining | PubMed |
| Evaluating whole-genome expression differences in idiopathic and diabetic adhesive capsulitis. | J Shoulder Elbow Surg | 2022 | 34352401 | PubTator, text mining | PubMed |
| IRE1 signaling regulates chondrocyte apoptosis and death fate in the osteoarthritis. | J Cell Physiol | 2022 | 34297411 | PubTator, text mining | PubMed |
| A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma. | Neuro Oncol | 2022 | 34232320 | PubTator, text mining | PubMed |
| The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes for Orthopedic Diseases Treatment. | Stem Cell Rev Rep | 2022 | 34169411 | PubTator, text mining | PubMed |
| Molecular and Histological Evidence Detailing Clinically Observed Skin Improvement Following Cryolipolysis. | Aesthet Surg J | 2022 | 34000047 | PubTator, text mining | PubMed |
| Molecular mechanisms and treatments for ocular symblephara. | Surv Ophthalmol | 2022 | 33932469 | PubTator, text mining | PubMed |
| Growth factor and macromolecular crowding supplementation in human tenocyte culture. | Biomater Biosyst | 2021 | 36825160 | PubTator, text mining | PubMed |
| Development of Fluorine-Free Tantalum Carbide MXene Hybrid Structure as a Biocompatible Material for Supercapacitor Electrodes. | Adv Funct Mater | 2021 | 35264918 | PubTator, text mining | PubMed |
| Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis. | Front Pharmacol | 2021 | 35126133 | PubTator, text mining | PubMed |
| MiR-29a Increase in Aging May Function as a Compensatory Mechanism Against Cardiac Fibrosis Through SERPINH1 Downregulation. | Front Cardiovasc Med | 2021 | 35118144 | PubTator, text mining | PubMed |
| Identification of hub genes in gastric cancer by integrated bioinformatics analysis. | Transl Cancer Res | 2021 | 35116593 | PubTator, text mining | PubMed |
| Laser Photobiomodulation 808 nm: Effects on Gene Expression in Inflammatory and Osteogenic Biomarkers in Human Dental Pulp Stem Cells. | Front Pharmacol | 2021 | 35111053 | PubTator, text mining | PubMed |
| Nanotechnology in Drug Delivery for Liver Fibrosis. | Front Mol Biosci | 2021 | 35087870 | PubTator, text mining | PubMed |
| Shifting Paradigms for Suppressing Fibrosis in Kidney Transplants: Supplementing Perfusion Solutions With Anti-fibrotic Drugs. | Front Med (Lausanne) | 2021 | 35083254 | PubTator, text mining | PubMed |
| Hsp47 Inhibitor Col003 Attenuates Collagen-Induced Platelet Activation and Cerebral Ischemic-Reperfusion Injury in Rats. | Front Pharmacol | 2021 | 35082674 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=42